Hepatitis Monthly

Published by: Kowsar

Association of Mutations in the Basal Core Promoter and Pre-core Regions of the Hepatitis B Viral Genome and Longitudinal Changes in HBV Level in HBeAg Negative Individuals: Results From a Cohort Study in Northern Iran

Sima Besharat 1 , 2 , Hossein Poustchi 1 , * , Ashraf Mohamadkhani 1 , Aezam Katoonizadeh 1 , Abdolvahab Moradi 2 , Gholamreza Roshandel 1 , 2 , Neal David Freedman 3 and Reza Malekzadeh 1
Authors Information
1 Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, IR Iran
2 Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences, Gorgan, IR Iran
3 Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland, USA
Article information
  • Hepatitis Monthly: February 28, 2015, 15 (2); e23875
  • Published Online: February 21, 2015
  • Article Type: Research Article
  • Received: September 24, 2014
  • Revised: October 28, 2014
  • Accepted: January 24, 2015
  • DOI: 10.5812/hepatmon.23875

To Cite: Besharat S, Poustchi H, Mohamadkhani A, Katoonizadeh A, Moradi A, et al. Association of Mutations in the Basal Core Promoter and Pre-core Regions of the Hepatitis B Viral Genome and Longitudinal Changes in HBV Level in HBeAg Negative Individuals: Results From a Cohort Study in Northern Iran, Hepat Mon. 2015 ; 15(2):e23875. doi: 10.5812/hepatmon.23875.

Copyright © 2015, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
4. Results
5. Discussion
  • 1. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 2. Shanmugam S, Velu V, Nandakumar S, Madhavan V, Shanmugasundaram U, Shankar EM, et al. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India. J Microbiol Biotechnol. 2008; 18(10): 1722-8[PubMed]
  • 3. Hadziyannis SJ. Natural history of chronic hepatitis B in Euro-Mediterranean and African countries. J Hepatol. 2011; 55(1): 183-91[DOI][PubMed]
  • 4. Kao JH. Role of viral factors in the natural course and therapy of chronic hepatitis B. Hepatol Int. 2007; 1(4): 415-30[DOI][PubMed]
  • 5. Sali S, Alavian SM, Foster GR, Keyvani H, Mehrnoosh L, Mohammadi N. Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up. Hepat Mon. 2013; 13(7)[DOI][PubMed]
  • 6. Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, et al. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study. J Infect Dis. 2006; 194(5): 594-9[DOI][PubMed]
  • 7. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008; 359(14): 1486-500[DOI][PubMed]
  • 8. Kitab B, Essaid El Feydi A, Afifi R, Trepo C, Benazzouz M, Essamri W, et al. Variability in the precore and core promoter regions of HBV strains in Morocco: characterization and impact on liver disease progression. PLoS One. 2012; 7(8)[DOI][PubMed]
  • 9. Tohme RA, Bulkow L, Homan CE, Negus S, McMahon BJ. Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010. J Clin Virol. 2013; 58(2): 396-400[DOI][PubMed]
  • 10. Alghamdi A, Aref N, El-Hazmi M, Al-Hamoudi W, Alswat K, Helmy A, et al. Correlation between hepatitis B surface antigen titers and HBV DNA levels. Saudi J Gastroenterol. 2013; 19(6): 252-7[DOI][PubMed]
  • 11. Mohamadkhani A, Jazii FR, Poustchi H, Nouraein O, Abbasi S, Sotoudeh M, et al. The role of mutations in core protein of hepatitis B virus in liver fibrosis. Virol J. 2009; 6: 209[DOI][PubMed]
  • 12. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009; 12(3): 225-31[PubMed]
  • 13. Gholamreza R, Shahryar S, Abbasali K, Hamidreza J, Abdolvahab M, Khodaberdi K, et al. Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population. Indian J Med Sci. 2007; 61(5): 263-8[PubMed]
  • 14. Pourshams A, Khademi H, Malekshah AF, Islami F, Nouraei M, Sadjadi AR, et al. Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol. 2010; 39(1): 52-9[DOI][PubMed]
  • 15. Semnani S, Sadjadi A, Fahimi S, Nouraie M, Naeimi M, Kabir J, et al. Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev. 2006; 30(1): 14-9[DOI][PubMed]
  • 16. Roshandel G, Sadjadi A, Aarabi M, Keshtkar A, Sedaghat SM, Nouraie SM, et al. Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med. 2012; 15(4): 196-200[PubMed]
  • 17. Mahboubi E, Kmet J, Cook PJ, Day NE, Ghadirian P, Salmasizadeh S. Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br J Cancer. 1973; 28(3): 197-214[PubMed]
  • 18. Gan RB, Chu MJ, Shen LP, Qian SW, Li ZP. The complete nucleotide sequence of the cloned DNA of hepatitis B virus subtype adr in pADR-1. Sci Sin B. 1987; 30(5): 507-21[PubMed]
  • 19. Ouneissa R, Bahri O, Alaya-Bouafif NB, Chouaieb S, Ben Yahia A, Sadraoui A, et al. Frequency and clinical significance of core promoter and precore region mutations in Tunisian patients infected chronically with hepatitis B. J Med Virol. 2012; 84(11): 1719-26[DOI][PubMed]
  • 20. Bozdayi AM, Bozkaya H, Turkyilmaz AR, Saryodlu M, Cetinkaya H, Karayalcin S, et al. Nucleotide divergences in the core promoter and precore region of genotype D hepatitis B virus in patients with persistently elevated or normal ALT levels. J Clin Virol. 2001; 21(1): 91-101[PubMed]
  • 21. Kim HJ, Yoo BC. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection]. Taehan Kan Hakhoe Chi. 2002; 8(2): 149-56[PubMed]
  • 22. Choi JW, Ahn SH, Park JY, Chang HY, Kim JK, Baatarkhuu O, et al. Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients. J Med Virol. 2009; 81(4): 594-601[DOI][PubMed]
  • 23. Jammeh S, Tavner F, Watson R, Thomas HC, Karayiannis P. Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol. 2008; 89: 901-9[DOI][PubMed]
  • 24. Yoo BC, Park JW, Kim HJ, Lee DH, Cha YJ, Park SM. Precore and core promoter mutations of hepatitis B virus and hepatitis B e antigen-negative chronic hepatitis B in Korea. J Hepatol. 2003; 38(1): 98-103[PubMed]
  • 25. Abbas Z, Muzaffar R, Siddiqui A, Naqvi SA, Rizvi SA. Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi. BMC Gastroenterol. 2006; 6: 20[DOI][PubMed]
  • 26. Zheng JX, Zeng Z, Zheng YY, Yin SJ, Zhang DY, Yu YY, et al. Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients. J Viral Hepat. 2011; 18(10)-31[DOI][PubMed]
  • 27. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst. 2008; 100(16): 1134-43[DOI][PubMed]
  • 28. Parekh S, Zoulim F, Ahn SH, Tsai A, Li J, Kawai S, et al. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol. 2003; 77(12): 6601-12[PubMed]
  • 29. Liu CJ, Jeng YM, Chen CL, Cheng HR, Chen PJ, Chen TC, et al. Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B. J Infect Dis. 2009; 199(5): 742-9[DOI][PubMed]
  • 30. Norouzi M, Ramezani F, Khedive A, H Karimzadeh H, Alavian SM, Malekzadeh R, et al. Hepatitis B Virus Genotype D is the Only Genotype Circulating in Iranian Chronic Carriers, the Unique Pattern of Genotypic Homogeneity. J Gastroenterol Hepatol Res. 2014; 3(9)
  • 31. Khedive A, Sanei-Moghaddam I, Alavian SM, Saberfar E, Norouzi M, Judaki M, et al. Hepatitis B virus surface antigen (HBsAg) mutations are rare but clustered in immune epitopes in chronic carriers from Sistan-Balouchestan Province, Iran. Arch Iran Med. 2013; 16(7): 385-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments